Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: RevitaCAM   
Auth. number : EU/2/12/138
INN : Meloxicam
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AC - Oxicams
Chemical substance: QM01AC06 - Meloxicam
(See WHO ATCvet Index)
Indication: Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs
Marketing Authorisation Holder: Abbott Laboratories Ltd
Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead SL6 4XE, United Kingdom

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/02/2012 Centralised - Authorisation EMEA/V/C/2379 (2012)1337 of 23/02/2012
26/09/2012 Centralised - Variation EMEA/V/C/2379/IB/1
Updated with Decision(2012)7891 of 29/10/2012
31/10/2012 Centralised - Variation (2012)7891 of 29/10/2012
05/04/2013 Centralised - Variation EMEA/V/C/2379/IB/3
Updated with Decision(2014)1733 of 12/03/2014
05/12/2013 Centralised - Variation EMEA/V/C/2379/IB/4
Updated with Decision(2014)1733 of 12/03/2014
14/03/2014 Centralised - Yearly update (2014)1733 of 12/03/2014